Compound Muscle Action Potential amplitude reproducibility as a function of site and size of the recording electrode.

Compound Muscle Action Potential amplitude reproducibility as a function of site and size of the recording electrode. - CMAP reproducibility as a function of site&size of the recording electrode

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34506

Enrollment

Registered

2010-06-10

Start date

2010-08-18

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

not applicable

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: aged between 18 and 50

Exclusion criteria

Exclusion criteria: evidence of diseases of or predisposing to peripheral nerve damage of the leg

Design outcomes

Primary

Measure	Time frame
CMAP parameters (latency, duration, amplitude and area of distally evoked CMAPs) as well as conduction parameters (motor nerve conduction velocity (MNCV), and the percentile changes of amplitude, duration and area over the length of nerve) described as means with standard deviation (SD), as well as with the coefficient of variation (CV).	—

Countries

Netherlands

Outcome results